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Abstract 
Introduction. High physical activity (PA) at old age indicates good functional capacity 
enabling independent living. We investigated how different disease conditions are associated 
with measured PA indicators in old women and men, and whether they recognize this 
association. 
Materials and methods. This cross-sectional twin cohort study in Finland comprised 779 
individuals (276 complete twin pairs, including 117 monozygotic pairs), who participated in 
hip-worn accelerometer monitoring of PA and responded to questions on diseases and 
mobility limitations at mean age of 73 (range 71 to 75). 
Results. Of the participants, 23.2% reported having a disease restricting mobility. With sex 
and age in the regression model, the reported disease restricting mobility explained 11.8% of 
the variation in moderate-to-vigorous PA and 10.4% of the variation in daily steps. Adding 
stepwise other self-reported diseases and body-mass index to the model increased the 
explanatory power for moderate-to-vigorous PA up to 18.5% and 25.5%, and for daily steps 
up to 16.0% and 20.7%, respectively. In the co-twin control analysis the PA differences were 
smaller in disease-discordant monozygotic than dizygotic pairs. 
Conclusions. Chronic disease conditions are associated with low PA, which individuals may 
not always recognize. Shared genetic factors may explain part of the associations.  
 
Key words: Disease, exercise, limitation of activity, monitoring, physical activity, sedentary 
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Key messages 
 Among community dwelling older men and women one fourth of the variation in 
objectively measured moderate-to-vigorous physical activity is accounted for by age, 
sex, body-mass index and self-reported diseases. 
 Occurrence of chronic diseases is associated with low physical activity and 
individuals do not always recognize this. 
 Healthcare professionals should pay attention to the low physical activity and 
mobility of individuals with chronic disease conditions before these result in 
limitations in independent living. 
 
 
  
Introduction 
 
Ageing-related overall degenerative processes or biological physiological aging as such (1), 
reduction of physical activity (PA) and development of specific chronic degenerative diseases 
(2-5) are all associated with the development of disability and mobility limitations. Exercise-
based rehabilitation has been shown to be a good means in improving both the measured and 
self-rated function among individuals with different chronic disease (6) and exercise 
interventions prevent occurrence of disability among the aged (7). High participation in 
moderate-to-vigorous physical activity (MVPA) at older age is an indicator of good physical 
fitness and health, and consequently predicts low risk of disability and death among older 
individuals (8,9). 
 
While overlapping among older people, PA level as such is not a direct indicator of mobility 
limitations, but high PA level quite directly indicates that the individual does not have 
significant physical mobility limitations. The prevalence of mobility limitations depends on 
the definition used (10). Difficulties related to walking or climbing stairs (11-13) as well as 
walking outdoors (14) are common indicators used to quantify physical mobility capabilities. 
 
In addition to low PA level, sedentary behaviour (SB) has been suggested to be detrimental to 
health in particular among those with low MVPA (Biswas et al. 2015, Ekelund et al. 2016, 
Patterson et al. 2018). Occurrence and progression of chronic diseases may lead to more 
sedentary lifestyle.    
 
Inter-individual genetic differences in the liability to develop obesity and many chronic 
diseases are substantial (15,16). Likewise, genetic factors affect fitness and participation in 
PA (17,18). However, in addition to genetic factors, there may also be factors related to 
childhood environment that predispose people to different clusters of these factors (8). 
Genetic pleiotropy (8,16) means that shared genetic factors may underlie both PA and disease 
risk providing an alternative explanation than a causal one to the observed association 
between PA and later disease.  
 
By studying outcomes in twin pairs discordant for exposure to different health habits and 
health outcomes, the possible confounding contributions of genetic and shared early 
childhood experiences can be taken into account. Twin pairs nearly always share the same 
childhood family environment. Dizygotic (DZ) pairs share, on average, half of their 
segregating genes (like siblings), while monozygotic (MZ) pairs are genetically identical at 
the sequence level. The co-twin control analyses among discordant monozygotic twin pairs, 
in particular, allow stronger estimates on causal influences compared to associations seen in 
unrelated individuals (19).    
 
In our 40-year longitudinal twin cohort study (MOBILETWIN study) we have previously 
analyzed the long-term predictors of later life PA but have identified only mid-life smoking 
as a factor causally influencing later life PA (20). Much of the association between mid-life 
and later life PA was explained by shared genetic factors (20). As it is largely unknown how 
we can influence the genetically determined ageing process we now investigated how chronic 
disease conditions are associated with objectively measured PA and SB in community 
dwelling twins with mean age of 73 years. Specifically, we 1) first tested the validity of a 
simple question on diseases restricting mobility against other more specific questionnaire 
items. Next, 2) we analyzed how the question on disease-related mobility restrictions was 
associated with objectively measured PA and SB characteristics. Thirdly, 3) we studied how 
other reported chronic diseases were associated with objectively measured PA and SB in 
addition to the self-reported disease-related mobility restrictions. Finally, 4) we analyzed 
whether members of DZ and MZ twin pairs discordant for self-reported diseases restricting 
mobility differed in their objectively measured PA and SB.     
 
Materials and methods 
This MOBILETWIN study (20) is an ancillary to the older Finnish Twin Cohort Study (21). 
Written informed consent was obtained from all participants. The study was approved by the 
Ethics Committee of the Hospital District of Southwest Finland on 20 May 2014.  
 
Participant inclusion and study design 
The study is based on a nationwide sample of all same-sex twin pairs born before 1958 with 
both co-twins alive in 1975 (21). A baseline questionnaire was sent to all twin candidates in 
1975. Among those whose addresses could be identified (93.5% of subjects) in 1975, the 
response rate for twins was 87.6%. A subsequent questionnaire was mailed in 1981 to all the 
verified twins. The corresponding response rate among those responding in 1975 and alive in 
1981 was 90.7%.  
 
For the current PA study (MOBILETWIN), twins from the 1940 – 1944 birth cohorts were 
selected (Figure 1). Altogether 3 186 twin individuals belonged to these birth cohorts and had 
responded to at least one of the questionnaires (1975 or 1981). A total of 145 twin individuals 
were excluded because they had participated in one of the previous studies on psychiatric 
disorders (schizophrenia and bipolar studies).  All remaining 816 (256 MZ, 490 DZ and 70 
with unknown zygosity) complete twin pairs, i.e., both alive and contactable, were invited to 
participate in the present study. The twins were sent an invitation letter in which they chose 
whether to participate in health and cognition telephone interview and/or accelerometer study 
completed with physical functioning questionnaire. Altogether 1012 (61.9%) twin individuals 
participated in the telephone interview, 791 twin individuals wore the accelerometer, and 817 
individuals filled in the whole questionnaire on physical functioning. The target group of this 
analysis were those 779 individuals (276 complete twin pairs; 117 MZ, 143 DZ and 16 pairs 
with unknown zygosity) who participated in telephone interview, objective PA monitoring 
and responded to the question on diseases restricting mobility. So, of the 1614 individuals 
alive on the day of the follow-up, 140 were not contactable (not community dwelling) and of 
the remaining 1474 individuals 779 (53%) participated in all parts of this follow-up study 
with required responses (for more details see Figure 1). Data was collected during 2014 to 
2016 starting from the oldest birth cohort. Accelerometer and questionnaire was mailed to 
each volunteering participants after the interview. The median time difference between the 
interview and accelerometer measurement was 17.5 days. According to the mid-life 
questionnaire data on PA, those who participated in this follow-up study and who did not 
participate had similar leisure-time PA levels (Waller et al. 2018), but at follow-up the target 
group was a selected community dwelling group as those less healthy individuals living in 
nursery homes were not contactable.    
 
Physician-diagnosed diseases and mobility limitations 
The participants were interviewed on their health and cognition and they responded to a 
questionnaire on mobility limitations. The questionnaire included a structured question ‘Do 
you have any physician-diagnosed disease which restricts your mobility?’ The response 
alternatives were ‘no’ and ‘yes’ followed by an open question on the disease restricting the 
mobility most. The questionnaire also included questions on whether the participant was able 
to walk a distance of 2 km and whether the participant was able to climb one flight of stairs. 
In both of these structured questions there were five response alternatives (22) as follows: 1) 
able to manage without difficulty, 2) able to manage with some difficulty, 3) able to manage 
with great deal of difficulty, 4) able to manage only with help of another person, and 5) 
unable to manage even with help. Those responding to alternatives 2, 3, 4 or 5 were classified 
as having difficulty. We also asked the participants to estimate with 0.5 km accuracy how 
many kilometers altogether they have walked or jogged outside during the past 7 days. Our 
telephone interview and/or questionnaire included a list of common physician-diagnosed 
chronic diseases, which may compromise person’s ability to be physically active. The 
interview included hypertension, coronary heart disease/myocardial infarction, stroke, 
peripheral arterial disease, heart failure, atrial fibrillation, diabetes, Parkinson’s disease, 
dementia, depression and diseases causing visual impairments and the questionnaire included 
separate items for rheumatoid arthritis, knee osteoarthritis, hip osteoarthritis, osteoporosis and 
arterial disease causing claudication.Body mass index (BMI) was calculated based on self-
reported (questionnaire) height and weight. 
 
Accelerometer data collection 
PA was measured with a hip-worn, light triaxial accelerometer (Hookie AM20, Traxmeet 
Ltd, Espoo). The device with the instructions for use was mailed to the participants, who 
were asked to use the accelerometer during waking hours (excluding activities in water) for 7 
consecutive days. Participants mailed the device back to the UKK Institute for data analysis. 
The analysis of raw acceleration (milligravity; 1mg = 0.00981 m/s2) data was based on novel 
algorithms that employ the mean amplitude deviation (MAD) of the resultant acceleration in 
6 s epochs and the angle for posture estimation (APE) of the body, metrics that provide 
consistent and accurate assessments of the intensity, volume and daily distribution for PA and 
separately the volume and its daily distribution for sedentary and stationary behaviors (23-
25).   
 
The MAD metric has been validated through directly measured incident oxygen uptake (VO2) 
during walking or running on an indoor track (24). This strong association allowed for 
conversion of MAD values to incident energy consumption (MET). The MET were smoothed 
by calculating the one-minute exponential moving average of MAD values for each 6s epoch. 
According to recommended use (26) cut-points for different activities were set as 1.5-3 MET 
for light activities, 3-6 MET for moderate activities, and over 6 MET for vigorous activities, 
and corresponding mean daily total times were determined. As vigorous activity was low in 
this age-group, MVPA variable was constructed by summing up the time of moderate and 
vigorous activities. Mean daily sedentary time was defined as MET under 1.5 during lying 
down or sitting. Mean daily standing time was analyzed separately. Average daily step count 
and the most intensive 10-minute period of PA (Peak-10min MET) during the monitoring 
week were also documented. When determining the Peak-10min MET, the accelerometer 
value of each epoch is first converted to MET value. Then, the Peak-10min MET value is the 
highest 10 min moving average MET value of the measurement week. 
 
Altogether, 791 twin individuals wore the accelerometer for at least 600 minutes per day for 4 
days. Final target group for this study was those individuals (N=779, mean age 73 years, 
range 71 to 75 years) who participated in objective PA monitoring and also responded to the 
structured question: Do you have a physician diagnosed disease which restricts your 
mobility? On average, these 779 individuals wore the device for a mean of 6.73 (95% CI 
6.69-6.77) days and mean 841 minutes (95% CI 835 –847  minutes) per day. 
 Statistical methods 
 
First, bootstrapping (1000 samples) was used to calculate statistical significances when 
comparing the questionnaire item on diseases restricting mobility against other questionnaire 
items on mobility difficulties and PA level. 
  
Our main analysis strategy was to investigate how much of the variation in PA was explained 
by the diseases, which the participants reported to restrict their mobility and to investigate 
whether reported chronic diseases not reported to restrict mobility were associated with low 
PA level also among those participants who did not report any mobility restricting disease. In 
addition, we analyzed the additional contribution of body-mass index in explaining the 
variation in PA. 
 
Results were calculated with bootstrapping (1000 samples unless otherwise noted) and are 
given as medians and their 95% confidence intervals (CIs) (Stata 12.0; Stata Corp., College 
Station, TX, USA). We used linear regression analyses to define R squared (R2) as a measure 
of variance accounted for. First, the analyses were done with twins treated as individuals; 
however, because of the clustering of twins within pairs (as the sampling unit was the twin 
pair), the observations obtained from twin pairs may be correlated, robust estimators of 
variance (the cluster option in Stata) were used (27). All basic analyses yielding R2 values 
were adjusted for age and sex. Square root-transformation for MVPA and log-transformation 
for Peak-10min MET were used for regression analyses because these variables were not 
normally distributed. Pairwise analyses among twin pairs (all pairs, DZ pairs, and MZ pairs 
separately) were done using Wilcoxon matched-pairs signed-rank test to discover if pairs 
discordant for reported diseases restricting mobility differed in the objectively measured PA 
or SB variables. 
 
Results  
 
The mean BMI of the participants was 26.11 kg/m2 (SD 3.92) with 15.2% of the participants 
having a BMI over 30 kg/m2.  
 
Questionnaire reports on diseases restricting mobility and physical mobility limitations 
Among the participants, nearly every fourth participant (23.2 %, 181 of 779) reported to have 
a disease that restricted their mobility. In the following open question the most common such 
diseases were musculoskeletal disease in 60.2% of cases (14% of all participants; 
osteoarthritis being the most common specific condition with 35.4% of the cases), followed 
by cardiovascular (18.8%), neurological (7.7%) and pulmonary (7.7%) diseases (Table I). 
Of the participants, almost every fifth (19.3%) reported at least some limitations in walking 
two kilometers. Among those who did not report diseases restricting mobility, 92.3% of 
participants reported no limitations in walking two kilometers while this proportion was 
43.1% in participants reporting restricting diseases (P<0.0001). Nearly every fourth 
participant (23.3%) reported at least some limitations in stair climbing. Among those who did 
not report diseases restricting mobility, 95.6% reported no limitations in climbing stairs, 
compared with 63.3% in participants reporting mobility restricting diseases (P<0.0001). 
 
Participants who reported having diseases restricting mobility reported their mean weekly 
distance of walking or jogging being 11.5 km (95% CI 9.9.-13.3 km) compared to 18.4 km 
(95% CI 17.2-19.6 km) in those reporting no restricting diseases (mean difference 6.9 km 
(95% CI 4.7-9.1 km). As a validity test we calculated (using bootstrapping) the correlation 
between the reported weekly distance of walking or jogging and objectively measured daily 
steps the Pearson correlation being r=.61 (95% CI .55-.66; P<.0001).  
 
Reported disease restricting mobility, other chronic diseases and objective physical 
activity measurement; individual-based analyses 
Distributions of the PA and SB variables in the target cohort are shown in Supplementary 
Table I. Expectedly, among those who reported diseases restricting their mobility the 
objectively measured sedentary time (lying and sitting) was longer and both light physical 
activity (LPA) and MVPA were lower as were the daily steps compared with those reporting 
no such diseases (Table II). Also, the intensity of the most intensive 10 minute PA period 
during the measurement week (Peak-10min MET) was lower among those reporting mobility 
restricting diseases. The mean difference in daily MVPA was 18 min (95% CI 14 to 22 min) 
and in daily steps 2247 (95% CI 1746 to 2746 steps) in favour of those not reporting a disease 
restricting their mobility. All the differences were rather similar among men and women 
(Table II) except for standing time with borderline statistically significant sex interaction 
(P=0.050). There was no difference in the daily measurement time between the groups. 
 
When looking at the physician-diagnosed diseases reported by the participants in the 
interview or questionnaire, expectedly there was substantial variation in the prevalence of the 
diseases by reporting any disease restricting mobility (Supplementary Table II). E.g., 44.0 % 
of those not reporting a disease restricting mobility reported having hypertension compared to 
60.3 % among those reporting restricting disease. The corresponding percentages were 4.4% 
vs. 14.2% for heart failure and 14.4% vs. 40.9% for knee osteoarthritis (Supplementary Table 
II). 
 Using linear regression analysis we estimated how much the reported diseases accounted for 
the variation in the PA characteristics. With sex and age in the model, the reported disease 
restricting mobility explained 11.8% of the variation in MVPA and 10.4% of the variation in 
daily steps (Table III). When adding different self-reported diseases separately to the 
regression model, each of eight diseases (hypertension, coronary heart disease or myocardial 
infarction, heart failure, atrial fibrillation, diabetes, rheumatoid arthritis, knee osteoarthritis, 
hip osteoarthritis) increased the explanatory power in the variation of MVPA more than 
0.1%. For the association between these selected reported diseases and MVPA see 
Supplementary Table III, and daily steps see Supplementary Table IV when the question on 
their mobility restrictions is ignored. In addition, increased number of reported diseases was 
associated with low physical activity (Supplementary Table V). After adding all these eight 
conditions to the previous model the fraction of variance accounted for increased to 18.5% 
for MVPA and 16.0% for daily steps. The explanatory fraction tended to be higher for 
women than men but the sex interaction was statistically non-significant (Table III). Adding 
BMI to the model further increased the fraction of variance accounted for MVPA to 25.5% 
and for daily steps to 20.7%. For results on other PA and SB variables, see Table III. 
 
When we combined the above mentioned eight diseases common in the older individuals but 
not always considered as a disease restricting mobility, we found that participants reporting 
these diseases, also among the group who did not report diseases restricting their mobility, 
had lower MVPA, daily steps and other physical activity level indicators than participants not 
reporting these diseases (Supplementary Table VI).  
 
Pairwise analysis 
There were 100 (63 DZ, 32 MZ, 5 with unknown zygosity) same-sex twin pairs who were 
discordant for reported chronic diseases restricting their mobility (Table IV). Among these 
pairs the objectively measured MVPA was higher in co-twins not reporting diseases 
restricting mobility compared to their co-twins with restricting disease (pairwise difference in 
median daily MVPA 11 min for all pairs [P<0.001 for pairwise difference], 15 min for DZ 
pairs [P<0.001] and 5 min for MZ pairs [P=0.009]). Also for other PA and SB characteristics 
the differences were smaller for MZ than for DZ pairs (Table IV). SB was higher among the 
co-twins with restricting disease (P<0.001). 
 
Discussion 
 
Among community dwelling older men and women one fourth of the variation in objectively 
measured MVPA was explained by age, sex, body-mass index and self-reported diseases. 
These variables explained more of the variation in MVPA than that of the low intensity 
activity or SB. Diseases that the participants recognized as reducing mobility accounted for 
only part of the variability and adding other reported diseases to a regression model increased 
the explanatory power of the model. Hence, participants did not always recognize that their 
diseases were associated with low PA level. 
 
Our study results are consistent with several earlier reports. The review by Brown and Flood 
(2) reported the risk factors most frequently identified as being independently associated with 
mobility limitation noted by five or more observational studies include older age, low PA, 
obesity, strength or balance impairments, and having chronic diseases such as diabetes or 
arthritis. Welmer et al. (3) found that body-mass index, coronary heart disease and heart 
failure are associated with mobility limitations. In addition to diseases, which according to 
the participants’ reports restrict their mobility, there were various common chronic diseases 
which associated with lower PA levels and increased sedentariness. In addition, higher 
number of diseases conditions associated with lower PA levels. Finally, we note that Smith et 
al. (28) found that chronic health status predicts nonparticipation in PA also after adjustment 
for self-reported health status. The associations of diseases with SB were weaker than those 
with PA, however, reducing SB may be an important and feasible way of maintaining 
mobility among aged with severe disease conditions.    
 
In our study cohort we had questionnaire data on the leisure-time PA of the participants in 
mid-life (in 1975, 1980 and 1990) (20). The participants reporting diseases causing mobility 
restrictions at follow-up did not differ significantly in leisure-time PA in mid-life from those 
reporting no diseases restricting mobility at follow-up (for more details see Supplementary 
Table VII), supporting the direct relation between the development of disease and mobility 
restrictions. Pairwise analyses showed that in the co-twin control design the differences in PA 
variables were smaller among MZ than among DZ pairs discordant for self-reported diseases 
restricting mobility. This is consistent with the previous finding that genetic factors 
contribute to the etiology of physical activity limitations (20). These findings together also 
suggest that reverse causality analyses are needed in studies evaluating the associations 
between PA and occurrence of diseases (8). 
 
It is important to pay attention to the declined fitness and PA level of older individuals, in 
particular if they have chronic diseases, as the slowly progressing diseases in the long-term 
are related with physical inactivity and further with physical disability. Either by maintaining 
PA levels or by using tailored exercise interventions (6,7) it is possible to improve the 
physical function of these individuals. In Finland, physicians are advised to recommend PA 
for patients who have diabetes or other chronic diseases, which may attenuate the 
associations seen in this study, but obviously there is an urgent need to increase the exercise 
counselling of patients with chronic disease to both maintain mobility and slow the 
progression of the diseases (6,29).  
 
Our results were also in agreement with the findings that overweight and obesity are 
associated with low PA and increased incidence of mobility limitations (30,31). There is 
accumulating data on that genetic pleiotropy may contribute to the co-existence of low PA, 
obesity and chronic disease (8,16,32). Our pairwise analyses also support the contribution of 
genetic pleiotropy contributing to the association between SB, PA and chronic disease, 
however, there was a difference in MVPA between the members of the disease-discordant 
MZ twin pairs. The contribution of genetic factors for physical activity level was shown by 
the previous finding that shared genetic factors explained most of the association between 
mid-life and later life PA levels (20). Also, there is the possibility for reverse causality, as 
some of the diseases such as hypertension do not cause immediate mobility limitations. 
Identifying chronic disease conditions and reductions in PA is most probably essential in 
identifying older risk persons needing preventive measures such as exercise-based 
rehabilitation to maintain their mobility.  
 
The strengths of our study include sampling from a large and population-based twin cohort 
including men and women and successful modern objective monitoring of PA and SB 
characteristics. The limitations of our study include that our data on chronic diseases relied 
on self-reports although they had to be physician-diagnosed. In order to maximize the 
participation rate, the participants were not invited to travel to laboratory examinations, 
which means that we have not measured their body composition or physical function at 
laboratory. Mobility limitations increase with increasing disease severity, but in our survey 
we were not able to do a severity classification of the diseases. At follow-up, all twins were 
community dwelling, therefore individuals with severe mobility limitations were rare, which 
needs to be taken into account when generalizing the results. 
 
In conclusion, occurrence of chronic diseases is associated with low PA and individuals do 
not always recognize this. Different modes of exercise therapy have previously been shown 
to be effective in improving both measured and self-reported functioning (6) and further the 
independent mobility. Healthcare professionals should pay attention to low PA and mobility 
of individuals with chronic disease conditions before these cause limitations in independent 
living. 
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 Figure and Table legends 
 
Figure 1. Study flow chart. 
 
Table I. Self-reported physician-diagnosed diseases restricting most mobility among those 
181 participants reporting a mobility restricting disease. 
Table II. Daily physical activity and sedentary behavior characteristics according to self-
reported physician-diagnosed diseases restricting mobility and sex. 
Table III. Reported diseases and body-mass index explaining variation in daily physical 
activity/sedentary behaviour characteristics.   
Table IV. Moderate-to-vigorous physical activity in twin pairs discordant for self-reported 
physician-diagnosed disease restricting mobility.  
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Table I. Self-reported physician-diagnosed diseases restricting most mobility among those 181 
participants reporting a mobility restricting disease. 
Disease N % % of all 779 
participants 
Musculoskeletal problems 
  Osteoarthritis 
  Rheumatoid arthritis 
  Other back-related 
  Other joint-related 
  Other musculoskeletal 
109 
  64 
  5 
  16 
  8 
  16 
60.2 
  35.4 
  2.8 
  8.8 
  4.4 
  8.8 
14.0 
  8.2 
  0.6 
  2.1 
  1.0 
  2.1 
Cardiovascular problems 
  Coronary heart disease or 
  Myocardial infarction 
  Heart arrhythmia   
  Heart failure 
  Valvular disease 
  Other cardiovascular 
34 
 
  10 
  9 
  4 
  3 
  8 
18.8 
 
  5.5 
  5.0 
  2.2 
  1.7 
  4.4 
4.4 
 
  1.3 
  1.2 
  0.5 
  0.4 
  1.0 
Neurological problems 
  (Poly)neuropathy 
  Parkinson’s disease 
  Stroke 
  Other neurological 
14 
  5 
  3 
  3 
  3 
7.7 
  2.8 
  1.7 
  1.7 
  1.7 
1.8 
  0.6 
  0.4 
  0.4 
  0.4 
Pulmonary disease 
  Asthma 
  COPD 
  Other pulmonary 
14 
  7 
  5 
  2 
7.7 
  3.9 
  2.8 
  1.1 
1.8 
  0.9 
  0.6 
  0.3 
Other 6 3.3 0.8 
No response 4 2.2 0.5 
Total 181 100 23.2 
 
  
Table II. Daily physical activity and sedentary behavior characteristics according to self-reported 
physician-diagnosed diseases restricting mobility and sex.* 
Activity/inactivity variable Reported disease restricting mobility (n of persons)  
All 
Men 
Women 
No (n=598) 
(n=293) 
(n=305) 
Yes (n=181) 
(n=85) 
(n=96) 
 
 Median (95% CI of median) P value† 
Sedentary time (lying and sitting)/day, min  
All 523 (514 to 532) 558 (545 to 574) <.0001 
Men 531 (520 to 550) 551 (529 to 588) .001 
Women 512 (501 to 526) 565 (544 to 590) <.0001 
Standing time/day, min  
All 86 (82 to 90) 70 (73 to 75) <.0001 
Men 79 (76 to 85) 73 (63 to 85) .218 
Women 91 (87 to 97) 67 (59 to 74) <.0001 
Time of light physical activity/day, min  
All 177 (171 to 182) 149 (145 to 160) .003 
Men 176 (170 to 184) 150 (145 to 170) .028 
Women 179 (165 to 183) 148 (134 to 165) .042 
Time of moderate-to-vigorous physical activity/day, min  
All 39 (37 to 43) 20 (17 to 25) <.0001 
Men 43 (37 to 47) 25 (18 to 32) <.0001 
Women 37 (34 to 39) 18 (13 to 24) <.0001 
Daily step count, number of steps  
All 6485 (6224 to 6742) 4085 (3680 to 4637) <.0001 
Men 6626 (6377 to 7117) 4442 (3805 to 5160) <.0001 
Women 6192 (5690 to 6711) 3812 (3145 to 4604) <.0001 
Peak-10min MET, MET  
All 3.65 (3.56 to 3.73) 2.99 (2.87 to 3.11) <.0001 
Men 3.67 (3.56 to 3.81) 3.10 (2.88 to 3.27) <.0001 
Women 3.60) (3.55 to 3.72) 2.92 (2.75 to 3.08) <.0001 
*All analyses with bootstrapping (1000). Activity variables calculated based on 1 minute exponential moving 
average. 
†P values for the difference between those with mobility restricting disease and those without from linear 
regression analysis adjusted for sex, age and cluster for family. 
  
Table III. Reported diseases and body-mass index explaining variation in daily physical 
activity/sedentary behaviour characteristics.   
Activity/inactivity 
variable 
R2 values from different regression models 
 
All 
Men 
Women 
Model 1 
n = 789 
n = 383 
n = 406 
Model 2 
n = 777 
n = 376 
n = 401 
Model 3 
n = 762 
n = 367 
n = 395 
Model 4 
n = 753 
n = 363 
n = 390 
 R2 
Sedentary time  
All 0.5%  5.5%  10.0%  13.0%  
Men 1.1%  5.2%  10.1%  15.6%  
Women 0.0%  6.0%  12.9%  13.8%  
Standing time  
All 0.7%  3.1%  8.0%  15.2%  
Men 1.7%  2.4%  8.8%  18.8%  
Women 0.0%  4.7%  10.9%  15.5%  
Light physical activity  
All 0.4% 1.7% 7.8% 10.2% 
Men 0.0% 1.3% 7.7% 12.5% 
Women 0.9% 2.3% 10.2% 11.2% 
Moderate-to-vigorous physical activity  
All 2.0%  11.8% 18.5% 25.5% 
Men 0.1% 6.6% 15.9% 27.0% 
Women 0.0% 14.5% 21.3% 25.5% 
Steps  
All 1.0% 10.4% 16.0% 20.7% 
Men 0.1% 7.6% 14.2% 23.9% 
Women 0.1% 11.4% 19.3% 20.5% 
Peak-10min MET  
All 1.1% 12.0% 20.4% 27.8% 
Men 0.0% 7.5% 18.9% 27.6% 
Women 0.0% 15.9% 24.7% 30.7% 
Model 1: Including sex and age. 
Model 2: Including sex, age and self-reported mobility restricting disease. 
Model 3. Including sex, age, self-reported mobility restricting disease and self-reported cardio-metabolic or 
arthritis diseases (hypertension, coronary heart disease/myocardial infarction, heart failure, atrial fibrillation, 
diabetes, rheumatoid arthritis, knee osteoarthritis, hip osteoarthritis). 
Model 4. Including variables in model 3 and body-mass index. 
All analyses with bootstrapping (1000) and including clustering for families. Activity variables calculated based 
on 1 minute exponential moving average. 
  
Table IV. Daily physical activity and sedentary behavior in twin pairs discordant for self-reported 
physician-diagnosed disease restricting mobility. 
 Mean time activity/daya 
hours:minutes:seconds 
Median (95% CI of median) 
Z, P valuec 
 1 – No disease 2 – Yes disease  
Sedentary time (lying and sitting)/day, h:min:sec 
All twin pairs 
(n=100) 
525 (506 - 554) 552 (538 - 589) Z=3.566, P<0.001 
DZ twin pairs (n=63) 519 (477 - 552) 558 (537 - 590) Z=3.498, P<0.001 
MZ twin pairs (n=32) 538 (514 - 587) 546 (520 - 623) Z=0.729, P=0.466 
Standing time/day, h:min:sec 
All twin pairs 89 (78 - 96) 70 (62 - 76) Z=2.921, P=0.003 
DZ twin pairs 85 (67 - 100) 70 (55 - 77) Z=2.386, P=0.017 
MZ twin pairs 93 (78 - 101) 75 (62 - 93) Z=1.253, P=0.210 
Time of light physical activity/day, h:min:sec 
All twin pairs 183 (157 - 197) 153 (146 - 175) Z=2.482, P=0.013 
DZ twin pairs 196 (172 - 215) 151 (145 - 186) Z=2.971, P=0.003 
MZ twin pairs 150 (132 - 181) 168 (141 - 189) Z=0.729, P=0.466 
Time of moderate-to-vigorous physical activity/day, min 
All twin pairs 33 (27 - 38) 22 (17 - 27) Z=4.965, P<0.001 
DZ twin pairs 32 (26 - 43) 17 (12 - 25) Z=4.108, P<0.001 
MZ twin pairs 32 (24 - 43) 28 (23 - 36) Z=2.599, P=0.009 
Daily step count, number of steps 
All twin pairs 6259 (5669 - 7167) 4510 (3986 - 5291) Z=4.937, P<0.001 
DZ twin pairs 6711 (5726  - 7983) 4220 (3403 - 5385) Z=4.183, P<0.001 
MZ twin pairs 5136 (4595 - 7406) 5041 (4103 – 6401) Z=1.739, P=0.082 
Peak-10min MET, MET 
All twin pairs 3.49 (3.28 – 3.82) 3.00 (2.89 – 3.15) Z=4.910, P<0.001 
DZ twin pairs 3.56 (3.23 – 3.83) 2.89 (2.73 – 3.02) Z=4.142, P<0.001 
MZ twin pairs 3.37 (3.22 – 4.11) 3.24 (3.09 – 3.40) Z=2.281, P=0.023 
aDescriptive analyses with bootstrapping (1000 samples unless otherwise noted) 
cZ as absolute value and P by Wilcoxon matched-pairs signed-rank test 
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Supplementary Table I. Distribution of physical activity and sedentary behavior variables in the target cohort 
of 779 participants (293 men and 305 women). 
Activity/inactivity variable Median (IQR from 25% to 75%) 
Sedentary time (lying and sitting)/day, min 
All 532 (466 to 595) 
Men 540 (474 to 598) 
Women 526 (454 to 583) 
Standing time/day, min 
All 82 (57 to 113) 
Men 78 (57 to 107) 
Women 86 (57 to 119) 
Time of light physical activity/day, min 
All 171 (133 to 214) 
Men 172 (130 to 214) 
Women 169 (134 to 211) 
Time of moderate-to-vigorous physical activity/day, min 
All 35 (18 to 56) 
Men 38 (21 to 63) 
Women 31 (17 to 50) 
Daily step count, number of steps 
All 5958 (4056 to 8516) 
Men 6376 (4513 to 8754) 
Women 5560 (3713 to 8261) 
Peak-10min MET, MET 
All 3.46 (2.93 to 4.14) 
Men 3.51 (2.99 to 4.20) 
Women 3.43 (2.91 to 4.05) 
*All analyses with bootstrapping (1000 repetitions). Activity variables calculated based on one minute 
exponential moving average. 
  
 
Supplementary Table II. Self-reported physician-diagnosed diseases by reporting any disease restricting 
mobility. 
Disease % (n) individuals reporting the physician diagnosed disease  
 All participants Reported the specific disease including in the cardio-
metabolic or arthritis disease cluster* 
  Did not self-report a 
disease restricting 
mobility 
Self-reported a 
disease restricting 
mobility 
P 
value† 
Hypertension 47.8 (369 of 772; ND 7) 44.0 (261) 60.3 (108) .001 
Coronary heart 
disease/MI 
12.1 (93 of 769; ND 10) 8.8 (52) 23.2 (41) <.001 
Heart failure 6.6 (51 of 767; ND 12) 4.4 (26) 14.2 (25) <.001 
Atrial fibrillation 9.5 (73 of 769; ND 10) 7.3 (43) 16.9 (30) .001 
Diabetes 14.0 (108 of 772; ND 7) 11.8 (70) 21.2 (38) .001 
Rheumatoid arthritis 4.7 (37 of 779;ND 0) 2.7 (16) 11.6 (21) <.001 
Knee osteoarthritis 20.5 (160 of 779; ND 0) 14.4 (86) 40.9 (74) <.001 
Hip osteoarthritis 7.6 (59 of 779; ND 0) 4.5 (27) 17.7 (32) <.001 
ND; not defined (either unclear status or no response)  
*Cardio-metabolic or arthritis disease cluster included hypertension, coronary heart disease/myocardial 
infarction, heart failure, atrial fibrillation, diabetes, rheumatoid arthritis, knee osteoarthritis, hip osteoarthritis. 
†By ꭙ2 test. 
  
Supplementary Table III. Daily moderate-to-vigorous physical activity according to self-reported disease.* 
Disease Moderate to vigorous physical activity, min   
 Without the disease With the disease  
 n 
Median 
(95% CI of median) 
P value† 
Hypertension 403 
39 
(35 to 44) 
369 
29 
(26 to 33) 
<.0001 
Coronary heart 
disease/MI 
676 
36 
(34 to 38) 
93 
25 
(18 to 32) 
<.0001 
Heart failure 716 
36 
(34 to 38) 
51 
18 
(11 to 27) 
<.0001 
Atrial fibrillation 696 
36 
(34 to 38) 
73 
25 
(18 to 30) 
<.0001 
Diabetes 664 
36 
(34 to 38) 
108 
25 
(15 to 35) 
<.0001 
Rheumatoid arthritis 742 
36 
(33 to 37) 
37 
16 
(11 to 27) 
<.0001 
Knee osteoarthritis 619 
37 
(34 to 39) 
160 
25 
(21 to 29) 
<.0001 
Hip osteoarthritis 720 
35 
(33 to 37) 
59 
24 
(17 to 35) 
.001 
*All analyses with bootstrapping (1000 samples unless otherwise noted). Activity variable calculated based on 
one minute exponential moving average 
†P values for the difference between those with the disease and those without from linear regression analysis 
adjusted for sex, age and cluster for family. 
  
 
Supplementary Table IV. Daily steps according to self-reported disease.* 
Disease N of steps  
 Without the disease With the disease  
 n 
Median 
(95% CI of median) 
P value† 
Hypertension 403 
6657 
(6275 to 7148) 
369 
5186 
(4857 to 5573) 
<.0001 
Coronary heart disease/MI 676 
6180 
(5890 to 6440) 
93 
4346 
(3805 to 5050) 
<.0001 
Heart failure 716 
6096 
(5821 to 6374) 
51 
4008 
(3233 to 4746) 
<.0001 
Atrial fibrillation 696 
6036 
(5758 to 6272) 
73 
4818 
(4285 to 6231) 
.002 
Diabetes 403 
6657 
(6275 to 7148) 
108 
4827 
(3988 to 5576) 
<.0001 
Rheumatoid arthritis 742 
6039 
(5758 to 6272) 
37 
3976 
(2911 to 5760) 
.004 
Knee osteoarthritis 619 
6156 
(5869 to 6453) 
160 
5329 
(4440 to 5767) 
.005 
Hip osteoarthritis 720 
6029 
(5759 to 6248) 
59 
4739 
(3633 to 6334) 
.017 
*All analyses with bootstrapping (1000 samples unless otherwise noted). Activity variable calculated based on 
one minute exponential moving average 
†P values for the difference between those with the disease and those without from linear regression analysis 
adjusted for sex, age and cluster for family. 
 
 
  
Supplementary Table V. Moderate-to vigorous physical activity and daily steps according to the number of 
self-reported diseases and sex.* 
Activity variable Disease status† 
 No reported disease 
 
1 reported disease 2 reported 
diseases 
3 or more reported 
diseases 
 N of persons in each cell 
All 
Men 
Women 
n = 259 
n = 122 
n = 137 
n = 246 
n = 110 
n = 136 
n = 171 
n = 89 
n = 82 
n = 103 
n = 57 
n = 46 
 Median 
(95% CI) 
Moderate-to-vigorous physical activity, min 
All 43 
(38 to 48) 
37 
(31 to 39) 
30 
(27 to 37) 
15 
(11 to 22) 
Men 48 
(40 to 56) 
42 
(36 to 44) 
37 
(30 to 48) 
17 
(11 to 24) 
Women 39 
(34 to 44) 
31 
(26 to 37) 
27 
(24 to 32) 
13 
(7 to 25) 
Steps 
All 6975 
(6431 to 7815) 
6114 
(5700 to 6610) 
5475 
(4979 to 5799) 
3765 
(3311 to 4405) 
Men 7903 
(6944 to 8439) 
6236 
(6058 to 6788) 
5728 
(5054 to 6544) 
4056 
(3544 to 4777) 
Women 6236 
(5847 to 7136) 
5450 
(4858 to 6656) 
5374 
(4795 to 5740) 
3215 
(2568 to 4405) 
*All analyses with bootstrapping (1000 repetitions). 
†Number of self-reported cardio-metabolic or arthritis disease cluster diseases (reported hypertension, 
coronary heart disease/myocardial infarction, heart failure, atrial fibrillation, diabetes, rheumatoid arthritis, 
knee osteoarthritis or hip osteoarthritis ignoring the reporting of mobility restricting disease). 
 
  
Supplementary Table VI. Daily physical activity/inactivity characteristics according to self-reported 
physician-diagnosed diseases restricting mobility and other physician diagnosed diseases and sex.* 
Activity variable Disease status 
 No reported disease 
 
Other reported 
disease† 
Reported disease 
restricting mobility 
 N of persons in each cell 
All 
Men 
Women 
n = 240 
n = 115 
n = 125 
n = 358 
n = 178 
n = 180 
n = 181 
n = 85 
n = 96 
 Median 
(95% CI) 
Sedentary time, min 
All 503 
(482 to 519) 
536 
(524 to 548) 
558 
(545 to 574) 
Men 514 
(487 to 531) 
549 
(531 to 558) 
551 
(529 to 588) 
Women 495 
(466 to 518) 
526 
(508 to 543) 
565 
(544 to 590) 
Standing time, min 
All 90 
(85 to 96) 
81 
(77 to 89) 
70 
(63 to 75) 
Men 83 
(73 to 89) 
78 
(74 to 85) 
73 
(63 to 85) 
Women 99 
(91 to 108) 
87 
(78 to 93) 
67 
(59 to 74) 
Light physical activity, min 
All 185 
(180 to 195) 
168 
(159 to 176) 
149 
(145 to 160) 
Men 190 
(180 to 200) 
169 
(155 to 179) 
150 
(145 to 170) 
Women 183 
(177 to 194) 
168 
(159 to 181) 
148 
(134 to 165) 
Moderate-to-vigorous physical activity, min 
All 45 
(39 to 49) 
37 
(33 to 40) 
20 
(17 to 25) 
Men 48 
(41 to 57) 
40 
(36 to 44) 
25 
(18 to 32) 
Women 41 
(36 to 48) 
34 
(27 to 37) 
18 
(13 to 24) 
Steps 
All 7145 
(6518 to 7965) 
6168 
(5686 to 6519) 
4085 
(3680 to 4637) 
Men 7823 
(6710 to 8468) 
6257 
(5989 to 6597) 
4442 
(3805 to 5160) 
Women 6475 
(6024 to 7830) 
5579 
(5131 to 6711) 
3812 
(3145 to 4604) 
Peak-10min MET 
All 3.79 
(3.63 to 4.00) 
3.56 
(3.44 to 3.67) 
2.99 
(2.87 to 3.11) 
Men 3.74 
(3.51 to 4.08) 
3.66 
(3.47 to 3.81) 
3.10 
(2.88 to 3.27) 
Women 3.88 
(3.63 to 4.03) 
3.44 
(3.28 to 3.60) 
2.92 
(2.75 to 3.08) 
*All analyses with bootstrapping (1000 repetitions). Activity variables calculated based on one minute 
exponential moving average 
†Self-reported cardio-metabolic or arthritis disease cluster (reported hypertension, coronary heart 
disease/myocardial infarction, heart failure, atrial fibrillation, diabetes, rheumatoid arthritis, knee 
osteoarthritis or hip osteoarthritis but did not report mobility restricting disease). 
  
 
Supplementary Table VII. Median of the mid-life mean MET-index from self-reported leisure-time physical 
activity in 1975, 1981 and 1990* according to self-reported physician-diagnosed diseases restricting mobility 
at follow-up and sex.† 
Activity/inactivity variable Reported disease restricting mobility (n of persons)  
All 
Men 
Women 
No (n=470) 
(n=215) 
(n=255) 
Yes (n=139) 
(n=71) 
(n=68) 
 
 Median (95% CI) P value‡ 
Mid-life leisure-time mean MET-index from years 1975, 1981 and 1990, MET-hours/day  
All 2.14 (1.94 to 2.29) 2.04 (1.63 to 2.37) .167 
Men 2.24 (2.02 to 2.63) 2.34 (1.57 to 2.74) .375 
Women 2.05 (1.80 to 2.29) 1.89 (1.48 to 2.24)  .301 
*Previous physical activity habits were assessed from the cohort by questionnaires in 1975, 1981 and 1990. All 
three questionnaires enabled calculation of the leisure-time MET-index. The MET-index was expressed as the 
sum-score of leisure-time physical activity MET-hours per day. To estimate the mean volume of physical 
activity during the three baseline survey years, the average of the MET index values obtained in 1975, 1981, 
and 1990 was computed and termed mid-life mean MET-index (see Waller et al. 2018). 
†All analyses with bootstrapping (1000). 
‡P values for the difference between those with the disease and those without from linear regression analysis 
adjusted for sex, age and cluster for family. 
